Application of multidisciplinary diagnosis and treatment in metastatic colorectal cancer

doi:10.3760/cma.j.cn371439-20220614-00136

Abstract

Abstract:

Colorectal cancer is one of the most common malignant tumors in the world， with a high mortality， but with the continuous improvement of diagnosis and treatment technology and treatment concept in recent years， many patients can get timely and effective treatment. From the aspects of distant metastasis of colorectal cancer and the progress of diagnosis and treatment under multidisciplinary diagnosis and treatment mode， focusing on the significance of multidisciplinary diagnosis and treatment mode for metastatic colorectal cancer， and exploring a more accurate and effective treatment system， so as to provide some reference for the comprehensive treatment of metastatic colorectal cancer.

Key words: Colorectal neoplasms, Multidisciplinary diagnosis and treatment, Distant metastasis

Sun Ziwen, Zhen Yanan, Chen Cunbao, Lu Shoutang. Application of multidisciplinary diagnosis and treatment in metastatic colorectal cancer[J]. Journal of International Oncology, 2022, 49(11): 692-695.

References 27

[1]	Anania G, Resta G, Marino S, et al. Treatment of colorectal cancer: a multidisciplinary approach[J]. J Gastrointest Cancer, 2019, 50(3): 458-468. DOI: 10.1007/s12029-018-0100-9. doi: 10.1007/s12029-018-0100-9 pmid: 29656351
[2]	葛剑力, 龚玮琦, 滕丽莉, 等. 全科医生视角下多学科诊疗模式探索[J]. 中国初级卫生保健, 2022, 36(3): 117-119. DOI: 10.3969/j.issn.1001-568X.2022.03.0035. doi: 10.3969/j.issn.1001-568X.2022.03.0035
[3]	匡晶晶, 苗毅. 一体化多学科协作诊疗模式在胰腺疾病诊疗中的实践[J]. 现代医院, 2021, 21(3): 368-370. DOI: 10.3969/j.issn.1671-332X.2021.03.013. doi: 10.3969/j.issn.1671-332X.2021.03.013
[4]	葛静, 张良明, 张千, 等. 多学科诊疗模式在某综合性医院的应用[J]. 安徽预防医学杂志, 2022, 28(1): 86-88. DOI: 10.19837/j.cnki.ahyf.2022.01.019. doi: 10.19837/j.cnki.ahyf.2022.01.019
[5]	Kaneko M, Ishihara S, Murono K, et al. Carbohydrate antigen 19-9 predicts synchronous peritoneal carcinomatosis in patients with colorectal cancer[J]. Anticancer Res, 2017, 37(2): 865-870. DOI: 10.21873/anticanres.11391. doi: 10.21873/anticanres.11391
[6]	Cremolini C, Loupakis F, Masi G, et al. FOLFOXIRI or FOLFOXIRI plus bevacizumab as first-line treatment of metastatic colorectal cancer: a propensity score-adjusted analysis from two randomized clinical trials[J]. Ann Oncol, 2016, 27(5): 843-849. DOI: 10.1093/annonc/mdw052. doi: 10.1093/annonc/mdw052 pmid: 26861604
[7]	Norén A, Sandström P, Gunnarsdottir K, et al. Identification of inequalities in the selection of liver surgery for colorectal liver metastases in Sweden[J]. Scand J Surg, 2018, 107(4): 294-301. DOI: 10.1177/1457496918766706. doi: 10.1177/1457496918766706 pmid: 29692213
[8]	郑波波, 胡涛, 邓祥兵, 等. MDT在同时性直肠癌肝转移的临床病例实践[J]. 中国普外基础与临床杂志, 2018, 25(3): 342-349. DOI: 10.7507/1007-9424.201712103. doi: 10.7507/1007-9424.201712103
[9]	Ren L, Zhu D, Benson AB 3rd, et al. Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019)[J]. Eur J Surg Oncol, 2020, 46(6): 955-966. DOI: 10.1016/j.ejso.2020.02.019. doi: S0748-7983(20)30121-9 pmid: 32147426
[10]	Okazaki S, Ishikawa T, Uetake H. Perioperative chemotherapies for patients with colorectal liver metastasis[J]. Gan To Kagaku Ryoho, 2020, 47(4): 574-577.
[11]	Zhai S, Sun X, Du L, et al. Role of surgical approach to synchronous colorectal liver metastases: a retrospective analysis[J]. Cancer Manag Res, 2021, 13: 3699-3711. DOI: 10.2147/CMAR.S300890. doi: 10.2147/CMAR.S300890 pmid: 33994810
[12]	于冠宇, 王薇, 龚海峰, 等. 乙状结肠癌伴肝巨大转移灶患者的MDT诊疗[J]. 实用肿瘤杂志, 2021, 36(6): 483-489. DOI: 10.13267/j.cnki.syzlzz.2021.097. doi: 10.13267/j.cnki.syzlzz.2021.097
[13]	Brännström F, Bjerregaard JK, Winbladh A, et al. Multidisciplinary team conferences promote treatment according to guidelines in rectal cancer[J]. Acta Oncol, 2015, 54(4): 447-453. DOI: 10.3109/0284186X.2014.952387. doi: 10.3109/0284186X.2014.952387 pmid: 25291075
[14]	王玉柳明, 胡汉卿, 王春林, 等. 3例结直肠癌肝转移患者行同期NOSES的MDT诊疗体会[J]. 结直肠肛门外科, 2022, 28(2): 171-176. DOI: 10.19668/j.cnki.issn1674-0491.2022.02.015. doi: 10.19668/j.cnki.issn1674-0491.2022.02.015
[15]	张钰洋, 陈善稳, 王鹏远, 等. 结直肠癌肝转移转化治疗的研究进展[J]. 中华胃肠外科杂志, 2021, 24(1): 85-93. DOI: 10.3760/cma.j.cn.441530-20200311-00135. doi: 10.3760/cma.j.cn.441530-20200311-00135
[16]	Han L, Xue J, Wu X, et al. Multidisciplinary approach to the diagnosis and treatment of patients with potentially resectable colorectal cancer liver metastasis: results of a multicenter study[J]. Ann Palliat Med, 2022, 11(2): 717-729. DOI: 10.21037/apm-22-87. doi: 10.21037/apm-22-87 pmid: 35249349
[17]	Wang Z, Wang X, Yuan J, et al. Survival benefit of palliative local treatments and efficacy of different pharmacotherapies in colorectal cancer with lung metastasis: results from a large retrospective study[J]. Clin Colorectal Cancer, 2018, 17(2): e233-e255. DOI: 10.1016/j.clcc.2017.12.005. doi: 10.1016/j.clcc.2017.12.005
[18]	李原, 林俊忠, 潘志忠. 1例结肠癌疑似肺转移患者的多学科综合治疗决策[J]. 结直肠肛门外科, 2020, 26(1): 102-104. DOI: 10.19668/j.cnki.issn1674-0491.2020.01.027. doi: 10.19668/j.cnki.issn1674-0491.2020.01.027
[19]	Siravegna G, Marsoni S, Siena S, et al. Integrating liquid biopsies into the management of cancer[J]. Nat Rev Clin Oncol, 2017, 14(9): 531-548. DOI: 10.1038/nrclinonc.2017.14. doi: 10.1038/nrclinonc.2017.14 pmid: 28252003
[20]	Grothey A, Sobrero AF, Shields AF, et al. Duration of adjuvant chemotherapy for stage Ⅲ colon cancer[J]. N Engl J Med, 2018, 378(13): 1177-1188. DOI: 10.1056/NEJMoa1713709. doi: 10.1056/NEJMoa1713709
[21]	Jamil A, Kasi A. Cancer, metastasis to the lung[M]. Treasure Island: Statpearls Publishing, 2020.
[22]	Rapicetta C, Lococo F, Davini F, et al. Is adjuvant chemotherapy worthwhile after radical resection for single lung metastasis from colorectal cancer? A multicentric analysis evaluating the risk of recurrence[J]. Front Oncol, 2019, 9: 763. DOI: 10.3389/fonc.2019.00763. doi: 10.3389/fonc.2019.00763 pmid: 31482063
[23]	Nozawa H, Ishihara S, Kawai K, et al. Characterization of conversion chemotherapy for secondary surgical resection in colorectal cancer patients with lung metastases[J]. Oncology, 2017, 92(3): 135-141. DOI: 10.1159/000453335. doi: 10.1159/000453335 pmid: 28052299
[24]	朱万莉, 张润冬, 张亚陆, 等. 结直肠癌肺转移的研究进展[J]. 重庆医学, 2021, 50(4): 689-693. DOI: 10.3969/j.issn.1671-8348.2021.04.033. doi: 10.3969/j.issn.1671-8348.2021.04.033
[25]	Vassos N, Piso P. Metastatic colorectal cancer to the peritoneum: current treatment options[J]. Curr Treat Options Oncol, 2018, 19(10): 49. DOI: 10.1007/s11864-018-0563-8. doi: 10.1007/s11864-018-0563-8
[26]	Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours[M]. 8th ed. New York: Wiley-Blackwell, 2017.
[27]	孙立峰, 童舟, 丁克峰. 外科肿瘤细胞减灭术联合腹腔内热灌注化疗——结直肠癌腹膜转移治疗的突破方向?[J]. 中华结直肠疾病电子杂志, 2015, 4(3): 234-239. DOI: 10.3877/cma.j.issn.2095-3224.2015.03. doi: 10.3877/cma.j.issn.2095-3224.2015.03